A complete Series B financial model for Healthcare Biotech startups. Revenue model, unit economics, hiring plan, cash flow projections, and funding scenarios — structured for investor review.
Projection Horizon
5 years with AOP detail for current year (monthly)
Model Tabs
8 core tabs
Format
Excel + Google Sheets
Path to profitability, market leadership, and capital efficiency. Series B investors are modeling the exit multiple — they want to see EBITDA timing and revenue quality.
Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts.
Series B models require a formal AOP (Annual Operating Plan) for the current year with monthly actuals-vs-plan tracking. Investors will ask for monthly actuals in the data room and will model variance trends.
Include a capital allocation memo that justifies the Series B use of proceeds. Show how each dollar maps to specific growth levers and the expected return on that investment.
A Series B Healthcare Biotech financial model should cover 5 years with AOP detail for current year (monthly) of projections with these tabs: Board-Level P&L Summary, Revenue Model by Segment, Sales Capacity Model, Headcount by Function, Departmental Budget vs. Actual, Balance Sheet Forecast, Cash Flow Statement, Capital Allocation Plan. Path to profitability, market leadership, and capital efficiency. Series B investors are modeling the exit multiple — they want to see EBITDA timing and revenue quality.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts. The key revenue drivers are: Patient volume x reimbursement rate by payer class; Commercial payer revenue (higher reimbursement); Medicare/Medicaid revenue (standardized rates); Enterprise health system contract revenue.
Healthcare Biotech unit economics at the Series B stage should include: Revenue per patient by payer type; Cost to serve per patient (clinical + overhead); Contribution margin per patient at break-even; Patient acquisition cost via provider referral; Prior authorization denial rate and cost impact. Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Series B models require a formal AOP (Annual Operating Plan) for the current year with monthly actuals-vs-plan tracking. Investors will ask for monthly actuals in the data room and will model variance trends. Start with the smallest unit of your business (one customer, one transaction, one seat) and build up from there. Every assumption should have a source or benchmark you can defend in an investor meeting.
Include a capital allocation memo that justifies the Series B use of proceeds. Show how each dollar maps to specific growth levers and the expected return on that investment.
Get the Healthcare Biotech Series B financial model as a pre-built Excel and Google Sheets template. Assumptions dashboard, revenue model, unit economics, and cash flow — ready to customize.
Includes Excel file, Google Sheets version, and model documentation guide